SPI Medical Imaging: Viz.ai and the Perils of Success

Published 22/04/2022

Written by

Alan Stoddart headshot
Alan Stoddart

Viz.ai has become medical imaging AI’s latest unicorn after its latest funding round, which saw it raise $100m at a $1.2bn valuation. The funding will mean Viz.ai can work towards its strategic objectives, but, will such figures also attract unwanted attention?

The insight is part of Signify Research’s Premium Insight – Medical Imaging subscription service.

To view the full insight on this development hit the Request Access button above for either a complimentary one month trial or to purchase a subscription.

The Signify Research’s Premium Insight – Medical Imaging subscription service provides:

  • Approximately 100 actionable and up to the moment Premium Insights per year.
  • A subscription to Signify Premium Insights – Medical Imaging provides compelling thought leadership on the most pertinent developments in healthcare technology.
  • This service utilises Signify Research’s expansive market data to properly appraise and interpret breaking news stories.
  • Major market moves and industry-changing announcements are evaluated as they unfold, and the considered opinions of Signify Research’s expert analysts are shared to provide insight into current developments.
  • Key vendors, technologies and conferences are followed, with updates carefully scrutinised to ensure that the most important details are revealed and properly assessed.